These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6323091)

  • 1. Cyclic AMP responses to parathyroid hormone and glucagon during lithium treatment.
    Waller DG; Albano JD; Millar JG; Polak A
    Clin Sci (Lond); 1984 May; 66(5):557-9. PubMed ID: 6323091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of cyclic AMP response to bovine parathyroid hormone in patients on chronic lithium therapy with diminished renal urine-concentrating ability.
    Waller DG; Albano JD; Millar JG; Polak A
    Clin Sci (Lond); 1983 Jun; 64(6):623-7. PubMed ID: 6301744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cyclic AMP hyper-response to glucagon in manic patients on lithium treatment.
    Okada F; Honma M; Ui M
    Int Pharmacopsychiatry; 1981; 16(4):193-200. PubMed ID: 6279537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR; Nickols GA; Anast CS
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.
    Rude RK; Oldham SB; Singer FR
    Clin Endocrinol (Oxf); 1976 May; 5(3):209-24. PubMed ID: 182417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.
    Kaminsky NI; Broadus AE; Hardman JG; Jones DJ; Ball JH; Sutherland EW; Liddle GW
    J Clin Invest; 1970 Dec; 49(12):2387-95. PubMed ID: 5480862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
    Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium does not inhibit the parathyroid hormone-mediated rise in urinary cyclic AMP and phosphate in humans.
    Spiegel AM; Gerner RH; Murphy DL; Aurbach GD
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1390-3. PubMed ID: 187615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotides in mental disorder.
    Belmaker RH; Zohar J; Ebstein RP
    Adv Cyclic Nucleotide Res; 1980; 12():187-98. PubMed ID: 6250353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
    Hendy GN; Tomlinson S; O'Riordan JL
    Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolonged lithium ingestion on glucagon and parathyroid hormone responses in rats.
    Olesen OV; Thomsen K
    Acta Pharmacol Toxicol (Copenh); 1974 Apr; 34(4):225-31. PubMed ID: 4364554
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistent nephrogenic diabetes insipidus, tubular proteinuria, aminoaciduria, and parathyroid hormone resistance following longterm lithium administration.
    Neithercut WD; Spooner RJ; Hendry A; Dagg JH
    Postgrad Med J; 1990 Jun; 66(776):479-82. PubMed ID: 2170960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cyclic AMP excretion in birds: dependence on parathyroid hormone activity.
    Pines M; Polin D; Hurwitz S
    Gen Comp Endocrinol; 1983 Jan; 49(1):90-6. PubMed ID: 6298061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors, adenylate cyclase, depression, and lithium.
    Belmaker RH
    Biol Psychiatry; 1981 Apr; 16(4):333-50. PubMed ID: 6261845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin on cortical adenylate cyclase activity and on urinary excretion of 3',5'-adenosine monophosphate in rat.
    Katzir Z; Wald H; Rubinger D; Popovtzer MM
    Miner Electrolyte Metab; 1989; 15(6):326-31. PubMed ID: 2482435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient renal cyclic adenosine 3'-5' monophosphate production in nephrogenic diabetes insipidus.
    Fichman MP; Brooker G
    J Clin Endocrinol Metab; 1972 Jul; 35(1):35-47. PubMed ID: 4338115
    [No Abstract]   [Full Text] [Related]  

  • 17. The relationship between thyroid function and the renal response to parathyroid hormone.
    Ashby JP; MacPherson JN; Strong JA
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):167-70. PubMed ID: 196793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone/adenylate cyclase coupling in vascular smooth muscle cells.
    Hanson AS; Linas SL
    Hypertension; 1994 Apr; 23(4):468-75. PubMed ID: 7511568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired renal response to parathyroid hormone in potassium depletion.
    Beck N; Davis BB
    Am J Physiol; 1975 Jan; 228(1):179-83. PubMed ID: 167590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible resistance to the renal action of parathyroid hormone in man.
    Tomlinson S; Hendy GN; Pemberton DM; O'Riordan JL
    Clin Sci Mol Med; 1976 Jul; 51(1):59-69. PubMed ID: 181194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.